Avidity Biosciences shares rise 3.80% intraday after presenting at Cantor Global and Wells Fargo conferences.

Avidity Biosciences, Inc. rose 3.80% intraday. The company's stock price increased following multiple presentations at industry conferences, including Cantor Global and Wells Fargo, where analysts Eric Schmidt and Yanan Zhu highlighted the company's potential. These presentations likely generated positive investor sentiment, contributing to the stock's upward movement.